DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Age-related Macular Degeneration Market 2016-2020" report to their offering.
The report forecasts the global age-related macular degeneration (AMD) market to grow at a CAGR of 7.37% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global age-related macular degeneration (AMD) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of AMD.
The report, Global Age-Related Macular Degeneration (AMD) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts.
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the strengths and weaknesses of the key vendors?
- Bayer HealthCare
- F. Hoffmann-La Roche
- Regeneron Pharmaceuticals
- Adverum Biotechnologies
- Bausch + Lomb
- Gilead Sciences
- Iconic Therapeutics
- Neurotech Pharmaceuticals
- Ohr Pharmaceutical
- Resolvyx Pharmaceuticals
- RXi Pharmaceuticals
- Sagent Pharmaceuticals
- Santen Pharmaceuticals
Sanwa Kagaku Kenkyusho
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Key buying criteria
PART 06: AMD: Overview
PART 07: Pipeline portfolio
PART 08: Market landscape
PART 09: Market analysis of major drugs
PART 10: Market segmentation by type
PART 11: Market segmentation by ROA
PART 12: Geographical segmentation
PART 13: Market drivers
PART 14: Impact of drivers
PART 15: Market challenges
PART 16: Impact of drivers and challenges
PART 17: Market trends
PART 18: Vendor landscape
PART 19: Key vendor analysis
PART 20: Appendix
PART 21: About the Author
For more information about this report visit http://www.researchandmarkets.com/research/mxr878/global